The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $74.52

Today's change0.00 0.00%
Updated April 27 4:00 PM EDT. Delayed by at least 15 minutes.
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $74.52

Today's change0.00 0.00%
Updated April 27 4:00 PM EDT. Delayed by at least 15 minutes.

Quest Diagnostics Inc closed at (U.S.)$74.52.

Shares have lost 2.14% over the last five days, but sit 4.86% below their 52-week high. This security has outperformed the S&P 500 by 20.18% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $74.52
  • High--
  • Low--
  • Bid / Ask(U.S.) $60.00 / (U.S.) $79.90
  • YTD % change+11.12%
  • Volume0
  • Average volume (10-day)1,770,728
  • Average volume (1-month)1,663,076
  • Average volume (3-month)1,616,743
  • 52-week range(U.S.) $54.90 to (U.S.) $78.33
  • Beta0.63
  • Trailing P/E21.33×
  • P/E 1 year forward15.61×
  • Forward PEG2.09×
  • Indicated annual dividend(U.S.) $1.52
  • Dividend yield2.04%
  • Trailing EPS(U.S.) $3.49
Updated April 27 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.25%

Based on its net profit margin of 7.25%, Quest Diagnostics Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue7,4351,9041,9021,746
Total other revenue--------
Total revenue7,4351,9041,9021,746
Gross profit2,819733732653
Total cost of revenue4,6161,1711,1701,093
Total operating expense6,4521,6481,6401,538
Selling / general / administrative1,705437434411
Research & development--------
Depreciation / amortization94242522
Interest expense (income), net operating--------
Unusual expense (income)44161012
Other operating expenses, total-7010
Operating income983256262208
Interest income (expense), net non-operating-167-42-42-40
Gain (loss) on sale of assets--------
Other--------
Income before tax849221229176
Income after tax587139142111
Income tax, total262828765
Net income556129133104
Total adjustments to net income-2-10-1
Net income before extra. items551129133104
Minority interest-36-10-9-7
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items549128133103
Inc. avail. to common incl. extra. items554128133103
Diluted net income554128133103
Dilution adjustment--------
Diluted weighted average shares145145145145
Diluted EPS excluding extraordinary itemsvalue per share3.790.880.920.71
Dividends per sharevalue per share1.290.330.330.30
Diluted normalized EPSvalue per share4.000.950.960.76